Next Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1571
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 14, 2019
Authors
Publisher
Wiley